NO PAIN PROJECT - ESTUDIO DEL DOLOR EN EL PACIENTE INCONSCIENTE.

Datos básicos

Código:
UMI-DEX-2018-01
Protocolo:
UMI-DEX-2018-01
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2019
Año de finalización:
2021
ESTUDIO OBSERVACIONAL NACIONAL

Objetivos del proyecto

Observaciones: Estado Comité: CONTRATO EN TRÁMITE

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

PAULA RAMÍREZ GALLEYMORE

Resultados del Ensayo Clínico


[Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].

Estella, Angel; (...); Zaragoza, Rafael

Article. 10.1016/j.medin.2021.04.007. 2021

  • Open Access.

[Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units].

Vidal-Cortes, Pablo; (...); Crespo, Rafael Zaragoza

Article. 10.1016/j.medin.2021.08.011. 2021

  • Open Access.

[Translated article] National registry and analysis of pharmaceutical interventions in critical care units: PHARMACRITIC study.

Cerezuela, Maria Martin; (...); Chiva, Esther Domingo

Article. 10.1016/j.farma.2024.10.003. 2024

  • Open Access.

Acceptance and validity of the methods used to implement a competency based medical education programme in an Intensive Care Department of a teaching referral center.

Castellanos-Ortega, A.; (...); Garcia-Ros, R.

Article. 10.1016/j.medin.2019.12.007. 2021


Acceptance and validity of the methods used to implement a competency based medical education programme in an Intensive Care Department of a teaching referral center.

Castellanos-Ortega A; (...); García-Ros R

Article. 10.1016/j.medine.2019.12.011. 2021


Activities of the clinical pharmacist in the intensive care units.

Becerril-Moreno F; (...); Cobo-Sacristán S

Article. 10.1016/j.farma.2024.09.004. 2024

  • Open Access.

Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain.

Ramírez P; (...); Castellanos Á

Article. 10.1016/j.medin.2020.06.015. 2021

  • Open Access.

Anti-endotoxin antibodies consumption in cardiovascular collapse: Pathophysiological concerns.

Villarreal, E.; (...); Vila, J.

Article. 10.1016/j.medine.2022.04.019. 2022


Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.

Ruiz-Ramos, Jesus, Gras-Martin, Laura, Ramirez, Paula

Article. 10.3390/antibiotics12030475. 2023

  • Open Access.

Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.

Cercenado, Emilia; (...); Retamar-Gentil, Pilar

Practice Guideline. 10.1016/j.eimce.2022.05.013. 2023


Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP

Cercenado, Emilia; (...); Retamar-Gentil, Pilar

Editorial Material. 10.1016/j.eimc.2022.05.005. 2023


Antimicrobial stewardship programs in the intensive care unit in patients with infections caused by multidrug-resistant gram-negative bacilli

Ramos, J. Ruiz, Galleymore, P. Ramirez

Article. 10.1016/j.medin.2022.07.007. 2023


Antimicrobial stewardship programs in the Intensive Care Unit in patients with infections caused by multidrug-resistant Gram-negative bacilli.

Ruiz-Ramos J, Ramírez P

Article. 10.1016/j.medine.2022.09.004. 2022


Antisepsis for blood culture extraction. Blood culture contamination rate

Galleymore, PR, Sahuquillo, MG

Article. 10.1016/j.medin.2018.08.007. 2019


Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2018.12.027. 2019


Beyond the Pandemic: The Value of Antimicrobial Stewardship

Kanj, Souha S., Ramirez, Paula, Rodrigues, Camilla

Article. 10.3389/fpubh.2022.902835. 2022

  • Open Access.

Biomarkers in pulmonary infections: a clinical approach.

Povoa, Pedro; (...); Kalil, Andre C

Article. 10.1186/s13613-024-01323-0. 2024

  • Open Access.

Biomarkers in the ICU: less is more? Yes.

Huang, David T., Ramirez, Paula

Editorial Material. 10.1007/s00134-020-06049-8. 2021

  • Open Access.

Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support.

Marín-Cerezuela M; (...); Ramirez P

Letter. 10.1186/s13054-024-05126-4. 2024

  • Open Access.

Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.

Martin-Cerezuela, M; (...); Galleymore, P R

Article. 10.1016/j.medin.2021.05.011. 2021


Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.

Martín-Cerezuela M; (...); Galleymore PR

Article. 10.1016/j.medine.2021.05.007. 2022


Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia.

Ruiz J; (...); Ramirez P

Article. 10.1177/1559325819885790. 2020

  • Open Access.

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2021.07.009. 2021


Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry

Madero Velazquez, L.; (...); Gutierrez-Casbas, A.

Meeting Abstract. 2024

  • Open Access.

Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial

Cisneros, JM; (...); Magic Bullet Working Grp WP1

Article. 10.1186/s13054-019-2627-y. 2019

  • Open Access.

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Megias-Vericat, JE; (...); Poveda, JL

Meeting Abstract. 2020


Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.

Vidal-Cortes, Pablo; (...); Zaragoza, Rafael

Review. 10.3390/antibiotics11091160. 2022

  • Open Access.

Decolonization strategies against multidrug resistant organisms in the ICU.

Póvoa P, Ramirez P, Blot S

Editorial Material. 10.1007/s00134-024-07360-4. 2024

  • Open Access.

Design of a new mortality indicator in acute coronary syndrome on admission to the Intensive Care Unit.

Lozano Gomez, Herminia; (...); Araiz Burdio, Juan Jose

Article. 10.1016/j.medine.2023.03.008. 2023


Design of a new mortality indicator in acute coronary syndrome on admission to the Intensive Care Unit

Gomez, Herminia Lozano; (...); Araiz Burdio, Juan Jose

Article. 10.1016/j.medin.2023.02.002. 2023

  • Open Access.

Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients

Ruiz-Gaitan, Alba; (...); Peman, Javier

Article. 10.1080/14787210.2019.1592675. 2019


Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections

Ruiz, J; (...); Castellanos-Ortega, A

Article. 10.1177/2050312120958897. 2020

  • Open Access.

Efficacy and Experience of Bacteriophages in Biofilm-Related Infections.

Gordon, Monica, Ramirez, Paula

Article. 10.3390/antibiotics13020125. 2024

  • Open Access.

Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group

Fernandez-Cooke, E; (...); KAWA-RACE Study Grp

Article. 10.1371/journal.pone.0215665. 2019

  • Open Access.

Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia.

Ceccato, Adrian; (...); Artigas, Antonio

Article. 10.3390/biomedicines11102676. 2023

  • Open Access.

Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption

Talavera, Monica; (...); Ramirez, Paula

Letter. 10.1016/j.medin.2023.04.013. 2023


Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption.

Talavera, Monica; (...); Ramirez, Paula

Case Reports. 10.1016/j.medine.2023.05.004. 2023


Fungal co-infection in COVID-19 patients: Should we be concerned?

Pemán J; (...); Quindós G

Review. 10.1016/j.riam.2020.07.001. 2020


How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.

Povoa, Pedro; (...); Kalil, Andre C.

Article. 10.1007/s00134-022-06956-y. 2023

  • Open Access.

Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.

Álvarez-Lerma F; (...); Martínez-Alonso M

Article. 10.1016/j.medine.2022.12.002. 2023


Impact of the ?Zero Resistance? program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study

Alvarez-Lerma, Francisco; (...); Martinez-Alonso, Montserrat

Article. 10.1016/j.medin.2022.12.002. 2023


Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019


In vitro study of antimicrobial activity on Klebsiella Pneumoniae biofilms in endotracheal tubes

Ruiz, J; (...); Ramirez, P

Article. 10.1080/1120009X.2019.1601801. 2019


Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1186/s13756-019-0484-8. 2019

  • Open Access.

Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019

  • Open Access.

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

  • Open Access.

Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality

Mendez, R; (...); Torres, A

Article. 10.1016/j.jinf.2019.04.006. 2019


Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

  • Open Access.

Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU.

Estella, A; (...); Zaragoza, R

Article. 10.1016/j.medine.2021.08.013. 2021

  • Open Access.

MINIMALLY INVASIVE VERSUS OPEN HYSTERECTOMY IN HIGH-RISK ENDOMETRIAL CANCER: A PROPENSITY SCORE MATCHING ANALYSIS

Segarra Vidal, B.; (...); Ramirez, P.

Meeting Abstract. 10.1136/ijgc-2021-ESGO.206. 2021

  • Open Access.

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021


Monographic: antisepsis in the critical patient Introduction

Ramirez, P., Nuvials, X., Diaz, E.

Editorial Material. 10.1016/j.medin.2018.07.018. 2019


New evidence in severe pneumonia: meropenem-vaborbactam.

Forteza Guillot, Maria, Martin Cerezuela, Maria, Ramirez, Paula

Article. 10.37201/req/s01.10.2022. 2022

  • Open Access.

Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data

Ruiz-Gaitan, AC; (...); Peman, Javier

Article. 10.1016/j.ijantimicag.2019.02.005. 2019


OUTCOMES FOLLOWING OPEN RADICAL HYSTERECTOMY AFTER IMPLEMENTATION OF AN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM

Agusti, N.; (...); Ramirez, P.

Meeting Abstract. 10.1136/ijgc-2021-ESGO.67. 2021

  • Open Access.

Pharmacist care in hospital emergency departments: a consensus paper from the Spanish hospital pharmacy and emergency medicine associations

Ramos, Jesus Ruiz; (...); Marco, Javier Povar

Article. 2023

  • Open Access.

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants

Jacqz-Aigrain, E; (...); Zhao, W

Article. 10.1093/jac/dkz158. 2019

  • Open Access.

Practical document on the management of hyponatremia in critically ill patients

Porcar, MJB; (...); Herrera-Gutierrez, ME

Article. 10.1016/j.medin.2018.12.002. 2019


Preoperative skin antisepsis

Galleymore, PR, Viera, V

Article. 10.1016/j.medin.2018.07.019. 2019


Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

  • Open Access.

Recomendaciones GEMICOMED/GEIRAS-SEIMC para el manejo de las infecciones y colonizaciones por Candida auris.

Alastruey-Izquierdo A; (...); en nombre de GEMICOMED GEIRAS-SEIMC

Abstract of Published Item. 10.1016/j.riam.2019.06.001. 2019


Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.

Vidal-Cortés P; (...); Zaragoza Crespo R

Practice Guideline. 10.1016/j.medine.2021.11.019. 2022

  • Open Access.

Reply to: "ormothermic regional perfusion - What is the benefit?''

Hessheimer, AJ; (...); Fondevila, C

Letter. 10.1016/j.jhep.2019.04.005. 2019

  • Open Access.

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry

Calafat, M; (...); Domenech, E

Meeting Abstract. 10.1093/ecco-jcc/jjy222.561. 2019


Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit.

Martín-Cerezuela M; (...); Ramírez-Galleymore P

Article. 10.1186/s13054-023-04347-3. 2023

  • Open Access.

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia.

van Oort PM; (...); Martin-Loeches I

Article. 10.1183/23120541.00212-2018. 2019

  • Open Access.

Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.

Candel, Francisco Javier; (...); Zaragoza, Rafael

Article. 10.3390/jcm12206526. 2023

  • Open Access.

Textbook outcome in patients with biliary duct injury during cholecystectomy.

Lopez-Lopez V; (...); Robles-Campos R

Article. 10.1016/j.gassur.2024.02.027. 2024


The challenge of multiresistant microorganisms.

Vicent C, Ramírez P

Editorial Material. 10.1016/j.medcli.2023.12.004. 2024

  • Open Access.

The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation

Hessheimer, AJ; (...); Fondevila, C

Letter. 10.1016/j.jhep.2019.01.004. 2019

  • Open Access.

Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020


Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients.

Martin-Loeches I; (...); Bermejo-Martín JF

Article. 10.1080/14787210.2023.2256979. 2023

  • Open Access.

Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.

Viale, Pierluigi; (...); Lodise, Thomas P.

Article. 10.1186/s13613-023-01146-5. 2023

  • Open Access.

Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020


Update of the treatment of nosocomial pneumonia in the ICU

Zaragoza, R; (...); Martin-Loeches, I

Review. 10.1186/s13054-020-03091-2. 2020

  • Open Access.

Análisis Epidemiológico, Clínico Y Microbiológico Del Brote De Candidiasis Invasora Por Candida Auris En El Hospital Universitario Y Politécnico La Fe

Autor/es: Alba Cecilia Ruiz Gaitán

Tesis Doctoral

Director/es: JAVIER PEMÁN GARCÍA; PAULA RAMÍREZ GALLEYMORE


Campos de estudio

Compartir